A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Stellate ganglion block

Ultrasound guided injection into the stellate ganglion performed in the right side of the neck in a sterile fashion.

DRUG

Bupivacaine

10 mL of 0.5% without epinephrine injected in the plane of the right stellate ganglion

DRUG

Placebo

10 mL of saline injected in the plane of the right stellate ganglion

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05357690 - A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation | Biotech Hunter | Biotech Hunter